This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.



  • Misuse of Common Antibiotic is Creating Resistant TB
    Use of a common antibiotic may be undercutting its utility as a first-line defense against drug-resistant tuberculosis (TB). Fluoroquinolones are the most commonly prescribed class of antibiotics in the U.S. and are used to fight a number of different infections such as ...More
    August 10, 2009 Posted in News
  • New Tuberculosis Blood Test Is Often "Indeterminate" in Children
    A new type of blood test for tuberculosis (TB) has important limitations for use in children—especially very young children and those with abnormal immune function, reports a study in the August issue of the Pediatric Infectious Disease Journal. Two accompanying ...More
    August 7, 2009 Posted in News
  • Higher Drug Doses Needed to Defeat Tuberculosis
    The typical dose of a medication considered pivotal in treating tuberculosis effectively is much too low to account for modern-day physiques, UT Southwestern Medical Center researchers say. The finding, reported online and in the August edition of Antimicrobial Agents and ...More
    July 30, 2009 Posted in News
  • TB 'Tracker' to Speed Drug and Vaccine Studies
    Johns Hopkins researchers have developed a novel way to monitor in real time the behavior of the TB bacterium in mouse lungs noninvasively pinpointing the exact location of Mycobacterium tuberculosis. The new monitoring system is expected to speed up what is currently a ...More
    July 22, 2009 Posted in News
  • Standard to Protect Against Infectious Airborne Diseases is First in the Nation
    The nation’s first standard to safeguard workers from the spread of airborne diseases has been approved by California’s Office of Administrative Law and filed with the Secretary of State. With full support from labor and management stakeholders, on May 21 the ...More
    July 8, 2009 Posted in News
  • Existing Parkinson’s Disease Drug May Fight Drug-Resistant TB
    Existing drugs used in the treatment of Parkinson's disease could be repositioned for use in the treatment of extensively drug-resistant tuberculosis, which kills about 2 million people each year, according to a study led by researchers at the University of California, ...More
    July 6, 2009 Posted in News
  • Measurements Fail to Identify TB Patients Who Could Benefit from Shorter Treatment Course
    Tuberculosis (TB) is a difficult infection to treat and requires six months of multiple antibiotics to cure it. To combat the TB pandemic, a shorter and simpler drug treatment would be a huge advance since most TB occurs in resource-limited settings with poor public health ...More
    June 30, 2009 Posted in News
  • Risk of TB from Arthritis Medication Examined
    Treatment with anti-tumor necrosis factor (TNF) agents is recognized as a risk factor for tuberculosis (TB) in patients with immune-mediated inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, Crohn's disease, psoriatic arthritis and psoriasis. Most ...More
    June 30, 2009 Posted in News
  • Scientists Solve Mystery About Why HIV Patients are More Susceptible to TB Infection
    A team of Harvard scientists has taken an important first step toward the development of new treatments to help people with HIV battle Mycobacterium tuberculosis (TB) infection. In their report, appearing in the July 2009 print issue of the Journal of Leukocyte Biology they ...More
    June 30, 2009 Posted in News
  • Fighting TB Might be a Matter of 'Flipping a Switch" in Immune Response
    Scientists are focusing on a new concept in fighting airborne pathogens by manipulating what is called the “switching time,” the point at which a highly regulated immune response gives way to powerful cells that specialize in fighting a specific invading bug.In ...More
    June 22, 2009 Posted in News